Literature DB >> 7051184

Prostacyclin is not a circulating hormone in man.

I A Blair, S E Barrow, K A Waddell, P J Lewis, C T Dollery.   

Abstract

A highly specific stable isotope dilution assay for plasma 6-oxo-prostaglandin F1 alpha has been developed. The method employs capillary column gas chromatography coupled with negative ion chemical ionisation mass spectrometry. The limit of sensitivity of the assay is 0.5 pg.m1(-1). Concentrations of 6-oxo-prostaglandin F1 alpha in the plasma of 20 healthy volunteers determined by this assay were all below 3 pg.m1(-1). The levels were much lower than any previously reported and confirms that prostacyclin is not a circulating hormone in man under normal physiological conditions.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7051184     DOI: 10.1016/0090-6980(82)90118-6

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  42 in total

1.  COX-2, the dominant source of prostacyclin.

Authors:  Emanuela Ricciotti; Ying Yu; Tilo Grosser; Garret A Fitzgerald
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-04       Impact factor: 11.205

2.  The effect of nifedipine, nimodipine and nisoldipine on agonist- and trauma-stimulated vascular prostacyclin synthesis in vitro.

Authors:  J Y Jeremy; D P Mikhailidis; P Dandona
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-01       Impact factor: 3.000

3.  Prostanoid synthesis by aortic rings in human blood: selective increase of prostacyclin mediated by a serum factor.

Authors:  J M Ritter
Journal:  Br J Pharmacol       Date:  1984-10       Impact factor: 8.739

Review 4.  Interactions of NSAIDs with diuretics and beta-blockers mechanisms and clinical implications.

Authors:  J Webster
Journal:  Drugs       Date:  1985-07       Impact factor: 9.546

5.  Contribution of prostaglandins to the systemic and renal vascular response to frusemide in normal man.

Authors:  I G Mackay; A L Muir; M L Watson
Journal:  Br J Clin Pharmacol       Date:  1984-05       Impact factor: 4.335

6.  Inhibition of platelet function by a controlled release acetylsalicylic acid formulation--single and chronic dosing studies.

Authors:  M S Roberts; L J McLeod; P A Cossum; J H Vial
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  In vivo production of prostacyclin and thromboxane in patients with acute myocardial infarction.

Authors:  P Henriksson; A Wennmalm; O Edhag; O Vesterqvist; K Green
Journal:  Br Heart J       Date:  1986-06

8.  Plasma 6-keto-PGF1 alpha, thromboxane B2 and PGE2 in type 1 (insulin-dependent) diabetic patients during exercise.

Authors:  T Mourits-Andersen; I W Jensen; P N Jensen; J Ditzel; J Dyerberg
Journal:  Diabetologia       Date:  1987-07       Impact factor: 10.122

9.  Identification of 13,14-dihydro-15-oxo-prostaglandin F2 alpha in the circulation during infusions of bradykinin and prostaglandin E2 in man.

Authors:  S E Barrow; J Cockcroft; C T Dollery; N E Hickling; J M Ritter
Journal:  Br J Pharmacol       Date:  1987-05       Impact factor: 8.739

10.  Changes of plasma thromboxane level in subarachnoid haemorrhage. A study with 11-dehydro-TXB2 as measuring index.

Authors:  S Suzuki; Y Nonogaki; K Ebina; T Sekiya; T Iwabuchi; M Takiguchi
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.